ClinicalTrials.gg
RecruitingNCT06070818Updated Oct 6, 2023

Healthy Body & Mind Program for Older Adults Living With Osteoarthritis and Cognitive Decline

An interventional study of Healthy Body & Mind Program in Cognitive Decline and Osteoarthritis, sponsored by The University of New South Wales. Recruiting at 1 site in Australia. Open to participants aged 55 Years and older. Per ClinicalTrials.gov, last updated 2023-10-06.

Sponsored by The University of New South Wales · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 4 months ago, but the record still lists the study as recruiting.
  • Started Sep 2023; still recruiting 3 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
55 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 57 studies in Cognitive Dysfunction with a site in Australia — 12 open to participants now, 22 under way, 9 of them phase 3. Cognitive Dysfunction · Australia.

Planned enrollment
47th of 51
20 · median 167
Started
2023
with 7 others
No phase
15 of 57
4 open now
Primary completion
2024-06
later than 2 of 21 live
Registered
48th of 57
by date
Lead sponsor
2 of 57
The University of New South Wales

Among the 57 studies in Cognitive Dysfunction with a site in Australia, this one is the 47th largest by planned enrollment of the 51 interventional ones that give a count, is one of 8 that started in 2023, is one of 15 with no phase, reaches primary completion later than 2 of the 21 other live ones, and was the 48th registered.

Cognitive Dysfunction

3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.

Browse Cognitive Dysfunction studies →

Open to participants now

12 of the 57 studies in Cognitive Dysfunction with a site in Australia are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Australia have not opened yet or have stopped. Only those recruiting at a site in Australia →

Who these studies take

Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.

This study: 55 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 57 studies in Cognitive Dysfunction with a site in Australia, or all of them as a file.
02

Study summary

The goal of this pilot randomised clinical trial is to compare a 12-week Healthy Body \& Mind Program to usual care in older adults living with cognitive decline and osteoarthritis.

The main questions it aims to answer are:

  • Does the Healthy Body \& Mind Program improve health-related quality of life in older adults living with cognitive decline and osteoarthritis (pre/post and intervention/control)?
  • Does the Healthy Body \& Mind Program improve other health outcomes (cognition, pain, anxiety/depression, physical function) in older adults living with cognitive decline and osteoarthritis (pre/post and intervention/control)?

Participants will complete a co-designed and multidisciplinary 12-week program that includes physical activity and lifestyle education (nutrition, social activity and managing anxiety/depression). Researchers will compare outcomes between the intervention group and a wait-list control to see if there are difference in outcome measures (quality of life, cognition, pain, anxiety/depression, physical function).

03

Conditions studied

  • Cognitive Decline
  • Osteoarthritis

Keywords

  • dementia
  • lifestyle
  • multidisciplinary
  • physical activity
  • nutrition
  • depression
  • anxiety
  • pain
  • osteoarthritis
  • cognitive decline
04

Who can participate

Ages eligible
55 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 55 or above.
  • score 18-25 indicating mild cognitive decline or mild dementia.
  • Diagnosed with osteoarthritis.
  • Able to safely undertake study assessments and complete exercise without assistance.

Exclusion criteria

Exclusion Criteria:

  • score below 18.
  • Display an abnormal cardiovascular response to exercise (as seen during the baseline exercise test) and your doctor does not provide medical clearance to exercise.
  • Are unable to speak English and do not have a translator.
  • Have orthopedic or neuromuscular limitations that prevent you from performing the exercise.
  • Are deemed unsuitable for group exercise sessions following initial assessment by an Accredited Exercise Physiologist within the UNSW Lifestyle Clinic.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Intervention

    Healthy Body \& Mind Program: In summary, the program includes two visits to the University of New South Wales (UNSW) Medicine \& Health Lifestyle Clinic at the beginning and end of the program for Initial and Final Assessments, and two weekly sessions for 12 weeks (24 sessions in total) to the UNSW Medicine \& Health Lifestyle Clinic to complete the Healthy Body \& Mind Program. Participants will also be invited to take part in a focus group either at the clinic or online (via Teams/ zoom) at the end of the program.

    Other: Healthy Body & Mind Program

  • No intervention
    Wait-list control

    Usual care. Participants will not be recruited if they are taking part in another research intervention or receiving treatment other than usual care.

Interventions

  • OtherHealthy Body & Mind Program

    12-week physical activity and lifestyle education program

06

What researchers measure

Primary outcomes

  1. Health-related quality of life questionnaire

    EuroQoL health-related quality of life (EQ-5D; https://euroqol.org/); Score range 0-1; 1 indicating full health, 0 indicating bad health.

    Time frame: 12 weeks

Secondary outcomes

  1. Cognition questionnaire

    Montreal Cognitive Assessment (MoCA); Score range 0-30; higher scores mean better cognition. Measure can also be broken down into subscales.

    Time frame: 12 weeks

Other outcomes

  1. Chronic pain questionnaire

    Western Ontario and McMaster Universities Arthritis Index (WOMAC); Score range 0-96; 0 represents best health, higher scores indicate more pain. Measure can also be broken down into subscales (e.g., pain and function).

    Time frame: 12 weeks

  2. Depression, anxiety & stress questionnaire

    Depression Anxiety Stress Scales (DASS-21); Score range 0-21; higher scores mean worse psychological health. Measure can also be broken down into subscales: depression, anxiety \& stress.

    Time frame: 12 weeks

  3. Physical function: 6-minute walk test

    Assesses distance in metres walked over 6 minutes as a sub-maximal test of aerobic capacity/endurance. Higher number of metres walked means better physical function and aerobic capacity.

    Time frame: 12 weeks

  4. Cardiovascular disease (CVD) risk profile questionnaire

    ADCVD (https://tools.acc.org/ascvd-risk-estimator-plus/#!/calculate/estimate/). Tool calculated % risk, higher % indicates greater risk for CVD.

    Time frame: 12 weeks

  5. Sleep questionnaire

    Pittsburgh Sleep Quality Index (PSQI); Score range 0-21; higher scores indicate worse sleep)

    Time frame: 12 weeks

  6. Physical function: handgrip strength physical test

    Accesses physical strength in kilograms (kg). Average score of 3 attempts on each hand using a dynamometer; higher kg indicates more strength.

    Time frame: 12 weeks

  7. Physical function: single leg stance test (balance) physical test

    Physical test used to assess static postural and balance control. The participant must stand unassisted on one leg and is timed in seconds from the time one foot is flexed off the floor to the time when it touches the ground or the standing leg or an arm leaves the hips. Higher number of seconds indicates better balance.

    Time frame: 12 weeks

07

Study locations

1 of 1 sites recruiting
  • UNSW Medicine & Health Lifestyle Clinic
    Sydney, New South Wales 2052, Australia
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2023 (actual). Primary completion is estimated for Jun 2024, 9 months after the start.

Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's planned 9 months is below that.

Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 25, 2023
First posted
Oct 6, 2023
StartActual
Sep 18, 2023
Primary completionEst.
Jun 26, 2024
CompletionEst.
Jul 28, 2024
Last update
Oct 6, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06070818
Lead sponsor
The University of New South Wales
Responsible party
Claire Burley (Principal Investigator Dr Claire Burley, The University of New South Wales) — Principal investigator
First posted
Oct 6, 2023
Start date
Sep 18, 2023
Primary completion
Jun 26, 2024 (estimated)
Completion
Jul 28, 2024 (estimated)
Last update
Oct 6, 2023

Study contacts

Claire Burley, PhD
Contact
c.burley@unsw.edu.au
+61 (2) 9065 3510
Belinda Parmenter, PhD
Contact
b.parmenter@unsw.edu.au
+61 (2) 9065 7411

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion